Monograph

A07AA09 - Vancomycin

Propably not porphyrinogenic

Rationale

Glycopeptide. Probably insignificant systemic exposure. Three references consider it safe.

Chemical description

Tricyclic glycopeptide antibioticum used in enterocolitis caused by Clostridium difficile. Given perorally in a dose of 500 mg (2 g) /d for 10-14 days.Only minute amounts are absorbed South African list: use. French list: authorized. Michael Moore's list: safe

Similar drugs

Explore alternative drugs in similar therapeutic classes A07A / A07AA or go back.

Tradenames and packages

From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.

Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.

Netherlands

Vancocin · Vancocin CP 250 mg, capsules · Vancomycine · Vancomycine Eureco-Pharma 250 mg harde capsules · Vancomycine Fresenius Kabi 1000 mg poeder voor concentraat voor oplossing voor infusie · Vancomycine Fresenius Kabi 500 mg poeder voor concentraat voor oplossing voor infusie · Vancomycine Medcor 250 mg, harde capsules · Vancomycine Strides 125 mg harde capsules · Vancomycine Strides 250 mg harde capsules

United Kingdom

Vancocin Matrigel · Vancocin Matrigel 125mg capsules · Vancocin Matrigel 250mg capsules · Vancomycin · Vancomycin 125mg capsules · Vancomycin 125mg/5ml oral solution · Vancomycin 125mg/5ml oral suspension · Vancomycin 20mg pastilles · Vancomycin 250mg capsules · Vancomycin 250mg/5ml oral solution · Vancomycin 250mg/5ml oral suspension · Vancomycin 50mg/5ml oral solution · Vancomycin 62.5mg/5ml oral solution

Denmark